In late 2013, just before I closed down the first iteration of The Life Product Review and joined MetLife, I wrote an article entitled Symetra’s Gambit. The crux of the article was that Symetra was carving out marketshare by offering artificially – and temporarily – cheap Guaranteed UL pricing in order to get a foot […]